Treatment of retinoblastoma in 2015 agreement and disagreement Journal Article
| Authors: | Abramson, D. H.; Shields, C. L.; Munier, F. L.; Chantada, G. L. |
| Article Title: | Treatment of retinoblastoma in 2015 agreement and disagreement |
| Abstract: | The management of intraocular retinoblastoma is rapidly changing, and even recent reviews on the subject are behind existing practices. The 4 authors of this report collectively represent their management strategies with an emphasis on areas of agreement and disagreement. Ophthalmic artery chemosurgery and intravitreous chemotherapy have completely replaced external beam radiotherapy, reduced the use of systemic chemotherapy, and diminished enucleations by 90% without evidence of compromising patient survival. © 2015 American Medical Association. All rights reserved. |
| Keywords: | cancer chemotherapy; cancer survival; cancer surgery; review; cancer adjuvant therapy; cancer patient; cancer radiotherapy; topotecan; disease association; carboplatin; melphalan; retinoblastoma; high risk patient; intermethod comparison; enucleation; external beam radiotherapy; chemosurgery; laser coagulation; cryotherapy; low level laser therapy; surgical patient; bilateral cancer; diode laser; priority journal; indirect ophthalmoscope |
| Journal Title: | JAMA Ophthalmology |
| Volume: | 133 |
| Issue: | 11 |
| ISSN: | 2168-6165 |
| Publisher: | American Medical Association |
| Date Published: | 2015-11-01 |
| Start Page: | 1341 |
| End Page: | 1347 |
| Language: | English |
| DOI: | 10.1001/jamaophthalmol.2015.3108 |
| PROVIDER: | scopus |
| PUBMED: | 26378747 |
| DOI/URL: | |
| Notes: | Export Date: 2 December 2015 -- Source: Scopus |
